Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2024 04:00 ET | Source: Laverock Therapeutics

Laverock Therapeutics to Present New Data on Programmable, Tunable, Stable and Specific Gene Silencing Platform at ESGCT

STEVENAGE, United Kingdom, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...
September 26, 2024 04:00 ET | Source: Laverock Therapeutics

Laverock Therapeutics makes significant advances in its unique programmable gene silencing platform and announces pipeline focus on advanced therapies in oncology and genetic diseases

Programmable, tunable, stable and specific gene silencing has been demonstrated across multiple target genes and multiple cell typesPoC achieved with concomitant silencing of more than one...
September 05, 2024 04:00 ET | Source: Laverock Therapeutics

Laverock Therapeutics announces forthcoming investor, scientific and partnering conference schedule

STEVENAGE, United Kingdom, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...
March 26, 2024 05:00 ET | Source: Laverock Therapeutics

Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team

STEVENAGE, United Kingdom, March 26, 2024 (GLOBE NEWSWIRE) -- Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced...